Category:

Press Releases

• • •

• • •

Zenas BioPharma Announces Key 2024 Accomplishments and 2025 Business Objectives to Support the Global Development and Commercialization of Therapies for Autoimmune Diseases

– Advancing Phase 2 and Phase 3 trials of obexelimab, a unique CD-19 x FcγRIIb inhibitor of B cell function- -Topline results from Phase 2 Trial in Relapsing Multiple Sclerosis (MoonStone) expected in third quarter 2025- -Topline results from pivotal Phase 3 Trial in Immunoglobulin G4-Related Disease (INDIGO) expected year-end

• • • Read More • • •

Surplus Solutions Expands Global Offerings with Refurbished Analytical and Medical Equipment, Supported by New Brand and Website Launch

Surplus Solutions Refurbished Equipment Surplus Solutions expands globally with Certified Surplus refurbished lab & medical equipment, a new brand, and website. WOONSOCKET, R.I., Feb. 04, 2025 (GLOBE NEWSWIRE) — Surplus Solutions, a global leader in Equipment Lifecycle Management (ELM) services, specializing in procuring and reselling laboratory, processing, and packaging equipment

• • • Read More • • •

Lantronix to Debut New LM4 AI-Powered Out-of-Band Management Platform at Cisco Live

LM4 Platform Brings Affordable Management Automation to IDFs and Small Sites LM4 Out-of-Band Management Platform The industry’s first console server designed for Intermediate Distribution Frames (IDF’s) IRVINE, Calif., Feb. 04, 2025 (GLOBE NEWSWIRE) — Lantronix Inc. (NASDAQ: LTRX), a global leader of compute and connectivity for IoT solutions enabling AI Edge

• • • Read More • • •

RECENT POSTS